Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Modern Hasen Pharma Building $43.6 Million Essential Drug Facility

publication date: Oct 25, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanghai Modern Hasen (Shangqiu) Pharmaceutical, a subsidiary of Shanghai Modern Pharmaceutical , announced plans to invest 277 million RMB ($43.6 million) to build a production facility in Shangqiu, Henan province. The new plant will produce drugs that are listed on the essential drug list. More details....

Stock Symbol: (SHA: 600420)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...